ANDA 214491, held by Deva Holding As. Succinylcholine Chloride.
As of Nov 16, 2026, ANDA 214491 (Succinylcholine Chloride), held by Deva Holding As, was first approved by FDA on Dec 21, 2020, with 0 approved supplements and 0 published complete response letters.
SUCCINYLCHOLINE CHLORIDE INJECTION, USP is indicated in adults and pediatric patients: as an adjunct to general anesthesia. to facilitate tracheal intubation. to provide skeletal muscle relaxation during surgery or mechanical ventilation.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 21, 2020 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Succinylcholine Chloride20MG/ML · injectable;injection | Succinylcholine Chloride | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters